Showing results (31-40 of 123) with videos related to
Sort By:
Pageof 13
Italian Journal of Neurological Sciences|June 1, 1984
Clinical application of the Mullen and Foster method for individualizing phenytoin dosageT Valenza, A Messori, G Zaccara, et al.Bone Marrow Transplantation|April 1, 1999
Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo OsseoA Messori, A Bosi, S Bacci, et al.Oncology Reports|June 16, 2000
Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experienceG Bellesi, L Rigacci, G Longo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
Cost-effectiveness of interferon in chronic myeloid leukaemia: analysis of four clinical studiesA MessoriComputer Methods and Programs in Biomedicine|March 1, 1997
Survival curve fitting using the Gompertz function: a methodology for conducting cost-effectiveness analyses on mortality dataA MessoriPharmacy World & Science : PWS|June 1, 1997
Current controversies in the application of meta-analysis (with special reference to oncological treatments)A MessoriPharmacoeconomics|April 7, 1997
Drug treatments for maintaining remission in Crohn's disease. A lifetime cost-utility analysisG Trallori, A MessoriComputer Methods and Programs in Biomedicine|August 1, 1993
Meta-analysis of clinical trials based on censored end-points: simplified theory and implementation of the statistical algorithms on a microcomputerA Messori, R RampazzoEuropean Review for Medical and Pharmacological Sciences|July 20, 2022
Treatments for relapsed-refractory diffuse large B-cell lymphoma: comparison of overall survival outcomes observed with four novel agentsA Messori, E CacceseClinical Drug Investigation|May 31, 2007
Lifetime cost-utility analysis of patients with refractory epilepsy treated with adjunctive topiramate therapy : cost-effectiveness in refractory epilepsyS Maltoni, A MessoriPageof 13